- Home
- SERA vs RPTX Comparison
SERA vs RPTX Comparison
Compare SERA & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SERA | RPTX |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.6M | 92.4M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SERA | RPTX |
|---|---|---|
| Price | $3.40 | $2.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 34.9K | ★ 1.1M |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $95,000.00 | ★ $11,870,000.00 |
| Revenue This Year | $217.92 | N/A |
| Revenue Next Year | $479.25 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.06 | N/A |
| 52 Week Low | $1.37 | $0.89 |
| 52 Week High | $9.13 | $4.07 |
Technical Indicators
Market Signals| Indicator | SERA | RPTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 66.44 |
| Support Level | $3.20 | $2.10 |
| Resistance Level | $3.18 | $2.30 |
| Average True Range (ATR) | 0.29 | 0.08 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 83.33 | 83.08 |
Price Performance
Historical ComparisonAbout SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.